Remus Pharmaceutical

REMUS
Price
-- --
 
Micro Cap
₹869 Cr.
Remus Pharmaceuticals Limited is a company focusing on the marketing and distribution of finished formulations and API of pharmaceutical drugs. It offers technical consultancy services to distributor… More
Remus Pharmaceuticals Limited is a company focusing on the marketing and distribution of finished formulations and API of pharmaceutical drugs. It offers technical consultancy services to distributors for preparing product registration reports. With a strong customer base including generic, regional, and multinational distributors, as well as hospitals and clinics in multiple countries, the company aims to build lasting relationships that improve patient lives. Less
Remus Pharmaceuticals Limited is a company focusing on the marketing and distribution of finished f… More
Remus Pharmaceuticals Limited is a company focusing on the marketing and distribution of finished formulations and API of pharmaceutical drugs. It offers technical consultancy services to distributors for preparing product registration reports. With a strong customer base including generic, regional, and multinational distributors, as well as hospitals and clinics in multiple countries, the company aims to build lasting relationships that improve patient lives. Less
Low
580
52W Range
High
994
PE
23.49
Sector PE
30.34
P/B
--
Div.Yield
0.14%
ROE
11.36%
EBIDTA
--
ROCE
15.69
EPS
--
WhatsApp

Get instant stock alerts

Recent events

  • News

  • Corporate Actions

Remus Pharmaceuticals Appoints Bhavik Shah As CFO Effective July 09, 2026
Jun 23, 2026
Remus Pharmaceuticals Says Anjali Shah Resigns As CFO
Jun 22, 2026
Remus Pharmaceuticals Re-Appoints Arpit Shah As MD
Aug 29, 2025
Remus Pharmaceuticals Incorporates Subsidiary For Clinical Trial Material Management
Jun 20, 2025
Remus Pharmaceuticals Acquiring Membership Interest Of 56.67% In Espee Global Holdings
Feb 07, 2024
Remus Pharmaceuticals To Sell Entire Stake In Unit Ratnatris Pharmaceuticals Via Shares Swap
Oct 19, 2023
Remus Pharmaceuticals To Make Strategic Investment In Espee Biopharma & Finechem LLC
Sep 15, 2023
Remus Pharmaceuticals Approved In Principle To Incorporate 2 Subsidiaries And 2 Wholly Owned Subsidiaries Outside India
Aug 04, 2023
Events:
Announcement Date
May 20, 2026
Dividend
Dividend of Rs.0.5 per share
Ex Date
Nov 14, 2025
Announcement Date
Nov 10, 2025
Dividend
Dividend of Rs.0.5 per share
Ex Date
Sep 18, 2025
Bonus
1 bonus shares for every 1 held. Bonus shares should be credited within 3 days after the ex-date.
Ex Date
Jul 04, 2025
Announcement Date
May 17, 2025
Dividend
Dividend of Rs.1 per share
Ex Date
Nov 19, 2024
Bonus
3 bonus shares for every 1 held. Bonus shares should be credited within 3 days after the ex-date.
Ex Date
Jun 06, 2024
Announcement Date
May 16, 2024
Dividend
Dividend of Rs.4 per share
Ex Date
May 02, 2024
Dividend
Dividend of Rs.2 per share
Ex Date
Oct 27, 2023
Announcement Date
Oct 19, 2023
Dividend
Dividend of Rs.2 per share
Ex Date
Sep 15, 2023

More Micro Cap Ideas

See similar 'Micro' cap companies with recent activity

Promoter Buying

Companies where the promoters are bullish

Capex

Companies investing on expansion

Superstar Investor

Companies where well known investors have invested